$1.600
+0.107 (+6.67%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Niki BioSolutions, Inc. (NIKI) Moving Averages Convergence Divergence (MACD) indicator is -0.77, suggesting NIKI is Strong sell.
Niki BioSolutions, Inc. (NIKI) 20-Day simple moving average is 1.98, while Niki BioSolutions, Inc. (NIKI) share price is $—, making it Sell.
Niki BioSolutions, Inc. (NIKI) 60-Day simple moving average is 4.68, while Niki BioSolutions, Inc. (NIKI) share price is $—, making it Sell.
Technical Analysis for NIKI
AI Technical NIKIAs of 2026-11-07, the technical board for Niki BioSolutions, Inc. (NIKI) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $1.60 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 18.693, MACD stands at -0.767 (Sell), Stochastic %K stands at 11.926 (Buy), Stochastic %D stands at 7.974 and CCI stands at -108.386 (Buy).
NIKI trades below the 60-day SMA (4.68) and below the 200-day SMA (6.55). Immediate resistance sits at Classic R1 2.13, then R2 2.50. Support sits at Classic S1 1.41, then S2 1.05.
Niki BioSolutions, Inc. (NIKI) Support & Resistance Level
Niki BioSolutions, Inc. (NIKI) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 18.693 |
| STOCHk_14_3_3 | 11.926 |
| STOCHd_14_3_3 | 7.974 |
| CCI_20 | -108.386 |
| AO_5_34 | -1.488 |
| MOM_10 | -0.250 |
| MACD_12_26_9 | -0.767 |
Niki BioSolutions, Inc. (NIKI) Relative Strength Index (RSI_14) is 18.693, creating a Buy signal.
Niki BioSolutions, Inc. (NIKI) Stochastic %K is 11.926, creating a Buy signal.
Niki BioSolutions, Inc. (NIKI) Stochastic %D is 7.974, creating a Buy signal.
Niki BioSolutions, Inc. (NIKI) CCI_20 is -108.386, creating a Buy signal.
Niki BioSolutions, Inc. (NIKI) Awesome Oscillator (AO) is -1.488, creating a Sell signal.
Niki BioSolutions, Inc. (NIKI) Momentum (MOM) is -0.250, creating a Sell signal.
Niki BioSolutions, Inc. (NIKI) Moving Average Convergence Divergence (MACD) is -0.767, creating a Sell signal.
Niki BioSolutions, Inc. (NIKI) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.644 | Sell |
| MA_10 | 1.768 | Sell |
| MA_20 | 1.976 | Sell |
| MA_60 | 4.683 | Sell |
| MA_200 | 6.550 | Sell |
| MA_250 | 6.550 | Sell |
Niki BioSolutions, Inc. (NIKI) 5-Day simple moving average is 1.644, while Niki BioSolutions, Inc. (NIKI) share price is $, making it a Sell.
Niki BioSolutions, Inc. (NIKI) 10-Day simple moving average is 1.768, while Niki BioSolutions, Inc. (NIKI) share price is $, making it a Sell.
Niki BioSolutions, Inc. (NIKI) 20-Day simple moving average is 1.976, while Niki BioSolutions, Inc. (NIKI) share price is $, making it a Sell.
Niki BioSolutions, Inc. (NIKI) 60-Day simple moving average is 4.683, while Niki BioSolutions, Inc. (NIKI) share price is $, making it a Sell.
Niki BioSolutions, Inc. (NIKI) 200-Day simple moving average is 6.550, while Niki BioSolutions, Inc. (NIKI) share price is $, making it a Sell.
Niki BioSolutions, Inc. (NIKI) 250-Day simple moving average is 6.550, while Niki BioSolutions, Inc. (NIKI) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.